These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

682 related items for PubMed ID: 25766835

  • 21. Parathyroid Klotho and FGF-receptor 1 expression decline with renal function in hyperparathyroid patients with chronic kidney disease and kidney transplant recipients.
    Krajisnik T, Olauson H, Mirza MA, Hellman P, Akerström G, Westin G, Larsson TE, Björklund P.
    Kidney Int; 2010 Nov; 78(10):1024-32. PubMed ID: 20686451
    [Abstract] [Full Text] [Related]

  • 22. The relationship between urinary kidney injury molecule-1 and blood bone metabolism markers in patients with chronic kidney disease
.
    Yin C, Cheng C, Wang J, Zhang L, Purrunsing Y, Yang G, Zeng M, Huang H, Ren W, Ye Y, Ma H, Xing C, Wang N.
    Clin Nephrol; 2020 Feb; 93(2):65-76. PubMed ID: 31793871
    [Abstract] [Full Text] [Related]

  • 23. [MORPHOGENETIC PROTEINS--FIBROBLAST GROWTH FACTOR AND KLOTHO, IN THE SERA OF PATIENTS WITH CHRONIC RENAL DISEASE].
    Milovanova LY, Kozlovskaya LV, Markina MM, Milovanova SY, Borisov AA, Mukhin NA, Fomin VV, Moiseev SV.
    Klin Med (Mosk); 2015 Feb; 93(12):32-8. PubMed ID: 27149811
    [Abstract] [Full Text] [Related]

  • 24. Randomized Clinical Trial of Sevelamer Carbonate on Serum Klotho and Fibroblast Growth Factor 23 in CKD.
    Liabeuf S, Ryckelynck JP, El Esper N, Ureña P, Combe C, Dussol B, Fouque D, Vanhille P, Frimat L, Thervet E, Mentaverri R, Prié D, Choukroun G, FRENCH Study collaborators.
    Clin J Am Soc Nephrol; 2017 Dec 07; 12(12):1930-1940. PubMed ID: 29074818
    [Abstract] [Full Text] [Related]

  • 25. Clinical significance of fibroblast growth factor-23 and soluble alpha klotho in different stages of chronic kidney disease.
    Khodeir SA, Okda HI, Abdalal HM.
    Saudi J Kidney Dis Transpl; 2019 Dec 07; 30(1):108-118. PubMed ID: 30804272
    [Abstract] [Full Text] [Related]

  • 26. In chronic kidney disease, serum α-Klotho is related to serum bicarbonate and proteinuria.
    Hage V, Pelletier S, Dubourg L, Drai J, Cuerq C, Lemoine S, Hadj-Aissa A, Laville M, Fouque D.
    J Ren Nutr; 2014 Nov 07; 24(6):390-4. PubMed ID: 25193108
    [Abstract] [Full Text] [Related]

  • 27. Diabetes modifies effect of high-phosphate diet on fibroblast growth factor-23 in chronic kidney disease.
    Muras K, Masajtis-Zagajewska A, Nowicki M.
    J Clin Endocrinol Metab; 2013 Dec 07; 98(12):E1901-8. PubMed ID: 24092829
    [Abstract] [Full Text] [Related]

  • 28. Fibroblast growth factor 23 and Klotho serum levels in healthy children.
    Gkentzi D, Efthymiadou A, Kritikou D, Chrysis D.
    Bone; 2014 Sep 07; 66():8-14. PubMed ID: 24880094
    [Abstract] [Full Text] [Related]

  • 29. Circulating concentration of FGF-23 increases as renal function declines in patients with chronic kidney disease, but does not change in response to variation in phosphate intake in healthy volunteers.
    Larsson T, Nisbeth U, Ljunggren O, Jüppner H, Jonsson KB.
    Kidney Int; 2003 Dec 07; 64(6):2272-9. PubMed ID: 14633152
    [Abstract] [Full Text] [Related]

  • 30. Association between FGF23, α-Klotho, and Cardiac Abnormalities among Patients with Various Chronic Kidney Disease Stages.
    Tanaka S, Fujita S, Kizawa S, Morita H, Ishizaka N.
    PLoS One; 2016 Dec 07; 11(7):e0156860. PubMed ID: 27400031
    [Abstract] [Full Text] [Related]

  • 31. Reduced renal α-Klotho expression in CKD patients and its effect on renal phosphate handling and vitamin D metabolism.
    Sakan H, Nakatani K, Asai O, Imura A, Tanaka T, Yoshimoto S, Iwamoto N, Kurumatani N, Iwano M, Nabeshima Y, Konishi N, Saito Y.
    PLoS One; 2014 Dec 07; 9(1):e86301. PubMed ID: 24466013
    [Abstract] [Full Text] [Related]

  • 32. Relationship between cFGF23/Klotho ratio and phosphate levels in patients with chronic kidney disease.
    Liu Z, Zhou H, Chen X, Chen H, Wang Y, Wang T, Cai L, Hong Y, Ke H, Zheng J.
    Int Urol Nephrol; 2019 Mar 07; 51(3):503-507. PubMed ID: 30689182
    [Abstract] [Full Text] [Related]

  • 33. Fibroblast Growth Factor 23 and α-Klotho Protein Are Associated with Adverse Clinical Outcomes in Non-Dialysis CKD Patients.
    Manou E, Thodis E, Arsos G, Pasadakis P, Panagoutsos S, Papadopoulou D, Papagianni A.
    Kidney Blood Press Res; 2020 Mar 07; 45(6):900-915. PubMed ID: 33040068
    [Abstract] [Full Text] [Related]

  • 34. The effect of GH treatment on serum FGF23 and Klotho in GH-deficient children.
    Efthymiadou A, Kritikou D, Mantagos S, Chrysis D.
    Eur J Endocrinol; 2016 Apr 07; 174(4):473-9. PubMed ID: 26764419
    [Abstract] [Full Text] [Related]

  • 35. The FGF23-Klotho axis and cardiac tissue Doppler imaging in pediatric chronic kidney disease-a prospective cohort study.
    Tranæus Lindblad Y, Olauson H, Vavilis G, Hammar U, Herthelius M, Axelsson J, Bárány P.
    Pediatr Nephrol; 2018 Jan 07; 33(1):147-157. PubMed ID: 28795324
    [Abstract] [Full Text] [Related]

  • 36. [FGF-23 and Klotho protein - new markers in chronic kidney disease?].
    Mituła I, Gołembiewska E, Ciechanowski K, Siuda A.
    Pol Merkur Lekarski; 2013 Apr 07; 34(202):235-8. PubMed ID: 23745333
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Impact of parathyroidectomy on serum FGF23 and soluble Klotho in hemodialysis patients with severe secondary hyperparathyroidism.
    Takahashi H, Komaba H, Takahashi Y, Sawada K, Tatsumi R, Kanai G, Suzuki H, Kakuta T, Fukagawa M.
    J Clin Endocrinol Metab; 2014 Apr 07; 99(4):E652-8. PubMed ID: 24476081
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 35.